Invention Application
- Patent Title: Immunogenic Compositions
-
Application No.: US16029878Application Date: 2018-07-09
-
Publication No.: US20190016775A1Publication Date: 2019-01-17
- Inventor: Joseph John Binder , Helen Kim Cho , Paul Jason Cockle , Derek John Falconer , Siradanahalli Guru , Marianne Marcela Andrea Martinic
- Applicant: Pfizer Inc.
- Main IPC: C07K14/705
- IPC: C07K14/705 ; C12N9/12
Abstract:
The present disclosure provides: (a) isolated immunogenic CEA polypeptides; (b) isolated nucleic acid molecules encoding (i) an immunogenic CEA polypeptide, (ii) an immunogenic CEA polypeptide and an immunogenic MUC1 polypeptide, (iii) an immunogenic CEA polypeptide and an immunogenic TERT polypeptide, or (iv) an immunogenic CEA polypeptide, an immunogenic MUC1 polypeptide, and an immunogenic TERT polypeptide; (c) compositions comprising an isolated nucleic acid molecule; and (d) methods relating to uses of the immunogenic CEA polypeptides, nucleic acid molecules, and compositions.
Information query
